🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Atazanavir (ATV) and fosamprenavir (fAPV) are new protease inhibitors that ...
Status
Completed
Location
Thomas Street Health Center
Start Date
2004-05
Trial ID
NCT00242216
Treatments Being Tested
This substudy is a prospective, observational, open-label, randomised study...
Status
Completed
Location
Fundación IDEAA
Start Date
2012-06
Trial ID
NCT01637233
This study will evaluate the non-inferiority of Stribild® (elvitegravir/cob...
Status
Completed
Location
Spectrum Medical Group
Start Date
2011-11
Trial ID
NCT01475838
The purpose of this randomized, open-label, multicenter, active-controlled ...
Status
Completed
Location
University of Alabama - Birmingham
Start Date
2010-11
Trial ID
NCT01252940
Treatments Being Tested
In subjects on boosted protease inhibitor (PI)-regimens who have elevated t...
Status
Completed
Location
Franco Felizarta, MD
Start Date
2009-09
Trial ID
NCT01010399
Treatments Being Tested
This study examines the impact of fosamprenavir as part of an ART on virolo...
Status
Completed
Location
Hospital Príncipe de Asturias
Start Date
2011-03
Trial ID
NCT01222611
Treatments Being Tested
The purpose of this study is to evaluate virological efficacy and safety of...
Status
Completed
Location
Service des Maladies infectieuses et tropicales Hopital Bichat Claude Bernard
Start Date
2005-12
Trial ID
NCT00122603
Treatments Being Tested
The objective of the OPTIMAL study is to demonstrate that the adjunction of...
Status
Completed
Location
Hôpital Henri Mondor
Start Date
2011-09
Trial ID
NCT01348308
Treatments Being Tested
For HIV-infected individuals with highly resistant viruses, higher drug lev...
Status
Terminated
Location
GSK Clinical Trials Call Center
Start Date
2005-03
Trial ID
NCT00144833
The primary objectives of this study are to evaluate the safety, tolerabili...
Status
Terminated
Location
University of Colorado Denver
Start Date
2013-08-26
Trial ID
NCT01923311
Treatments Being Tested